CL2009001156A1 - Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares. - Google Patents
Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares.Info
- Publication number
- CL2009001156A1 CL2009001156A1 CL2009001156A CL2009001156A CL2009001156A1 CL 2009001156 A1 CL2009001156 A1 CL 2009001156A1 CL 2009001156 A CL2009001156 A CL 2009001156A CL 2009001156 A CL2009001156 A CL 2009001156A CL 2009001156 A1 CL2009001156 A1 CL 2009001156A1
- Authority
- CL
- Chile
- Prior art keywords
- prophylaxis
- acetate
- alone
- useful
- conjunction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Acetato de un péptido de 12 aminoácidos; método de preparación; composición farmacéutica y agente que lo contiene, solo o conjuntamente con un principio activo que daña el ácido nucleico; útil para el tratamiento o profilaxis de trastornos proliferativos celulares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5319008P | 2008-05-14 | 2008-05-14 | |
US11684908P | 2008-11-21 | 2008-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009001156A1 true CL2009001156A1 (es) | 2010-08-27 |
Family
ID=40886711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009001156A CL2009001156A1 (es) | 2008-05-14 | 2009-05-13 | Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20100112089A1 (es) |
CN (1) | CN102149725A (es) |
AR (1) | AR071774A1 (es) |
CL (1) | CL2009001156A1 (es) |
PE (1) | PE20091924A1 (es) |
RU (1) | RU2010150964A (es) |
TW (1) | TW201000116A (es) |
UY (1) | UY31826A (es) |
WO (1) | WO2009139497A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114966050A (zh) * | 2012-03-18 | 2022-08-30 | 镜株式会社 | 疾病样品分析装置、分析系统及分析方法 |
JP6401255B2 (ja) * | 2013-06-24 | 2018-10-10 | 株式会社 キャンバス | ペプチド及びペプチド模倣物の併用並びに癌患者亜集団の処置 |
GB201401877D0 (en) | 2014-02-04 | 2014-03-19 | Univ Tromsoe | Peptides |
US10149887B2 (en) * | 2015-10-23 | 2018-12-11 | Canbas Co., Ltd. | Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment |
TWI805542B (zh) * | 2015-10-23 | 2023-06-21 | 日商坎巴斯有限公司 | 用於癌症治療之肽及擬肽與t細胞活化劑及/或查核點抑制劑之組合 |
AU2016355268B2 (en) | 2015-11-20 | 2021-08-19 | Senhwa Biosciences, Inc. | Combination therapy of tetracyclic quinolone analogs for treating cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2239037T3 (es) * | 1999-09-22 | 2005-09-16 | Canbas Co., Ltd. | Metodos y composiciones para inhibir la deteccion del ciclo celular en g2 y sensibilizar celulas a agentes dañinos del dna. |
KR100863090B1 (ko) * | 2002-01-17 | 2008-10-13 | 다케다 파머수티컬 컴패니 리미티드 | 항증식 활성을 지니고/지니거나 핵산 손상제 또는 처리제를 증강시키는 펩티드 및 펩티드모방체 |
US7125842B2 (en) * | 2003-04-07 | 2006-10-24 | Canbas Co. Ltd. | Anti-fungal compounds and methods of use |
EP1664340A1 (en) * | 2003-08-08 | 2006-06-07 | Canbas Co., Ltd. | Sensitivity test to predict efficacy of anti-cancer therapies |
AU2006201635A1 (en) * | 2005-10-20 | 2007-05-10 | Ludwig Institute For Cancer Research | Novel inhibitors and methods for their preparation |
CA2666184A1 (en) * | 2006-10-11 | 2008-04-17 | Medvet Science Pty. Ltd. | The use of a dna damaging agent and a ligand for the treatment of cancer |
-
2009
- 2009-05-13 PE PE2009000669A patent/PE20091924A1/es not_active Application Discontinuation
- 2009-05-13 US US12/465,536 patent/US20100112089A1/en not_active Abandoned
- 2009-05-13 UY UY0001031826A patent/UY31826A/es not_active Application Discontinuation
- 2009-05-13 RU RU2010150964/04A patent/RU2010150964A/ru not_active Application Discontinuation
- 2009-05-13 TW TW098115779A patent/TW201000116A/zh unknown
- 2009-05-13 AR ARP090101720A patent/AR071774A1/es not_active Application Discontinuation
- 2009-05-13 CL CL2009001156A patent/CL2009001156A1/es unknown
- 2009-05-13 WO PCT/JP2009/059238 patent/WO2009139497A1/en active Application Filing
- 2009-05-13 CN CN2009801279086A patent/CN102149725A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
AR071774A1 (es) | 2010-07-14 |
RU2010150964A (ru) | 2012-06-20 |
WO2009139497A1 (en) | 2009-11-19 |
UY31826A (es) | 2010-01-05 |
PE20091924A1 (es) | 2010-01-04 |
CN102149725A (zh) | 2011-08-10 |
US20100112089A1 (en) | 2010-05-06 |
TW201000116A (en) | 2010-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009001156A1 (es) | Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares. | |
MX2014007233A (es) | Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados. | |
BR112013018352A2 (pt) | composição de minociclina tópica e método | |
BR112014004460A2 (pt) | material polimérico para um recipiente isolado | |
PE20130579A1 (es) | Composiciones y metodos para suministro al sistema nervioso central de iduronato-2-sulfatasa | |
MX2014004725A (es) | Formulaciones de etanercept estabilizadas con aminoacidos. | |
PE20110302A1 (es) | Formulacion farmaceutica de un anticuerpo contra p-selectina | |
IN2014KN01716A (es) | ||
IN2014KN01714A (es) | ||
MX360208B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
WO2012103038A9 (en) | Nanoparticle compositions, formulations thereof, and uses therefor | |
BR112012016749A2 (pt) | "d-aminoácido para uso no tratamento de biofilmes" | |
WO2007125501A3 (en) | Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness | |
MX2014001372A (es) | Composicion farmaceutica para el tratamiento y/o prevencion de cancer pancreatico. | |
WO2012145665A3 (en) | Method of drug delivery for pth, pthrp and related peptides | |
UY31209A1 (es) | Uso de homo y copolimeros para la estabilización de formulaciones de principios activos | |
MX2013010497A (es) | Inhibidores potentes y selectivos de nav1.3 y nav1.7. | |
WO2008128775A3 (en) | Stabilised pharmaceutical composition containing pregabaline | |
WO2011146922A3 (en) | Materials and methods for treatment of inflammation | |
AR082805A1 (es) | PEPTIDO O COMPLEJO PEPTIDICO QUE SE UNE A INTEGRINA a2 Y METODOS Y USOS QUE IMPLICAN A LOS MISMOS | |
CL2009000803A1 (es) | Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada | |
BR112012027080A2 (pt) | composições orgânicas para tratar doenças relacionadas a beta - ena | |
NZ631131A (en) | Reconstituted hdl formulation | |
BR112013004455A2 (pt) | composições para fornecimento gástrico de agentes ativos | |
BR112019003136A2 (pt) | forma de dosagem multiunitária de composição farmacêutica, forma de dosagem unitária de composição farmacêutica, forma de dosagem multiunitária / unitária, kit e método de tratamento de uma condição tratável por administração oral de um agente terapeuticamente ativo |